Strategic Partners A/S
Strategic Partners A/S (OZYMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OZYMF · as of Jun 9, 2026
Key Statistics
Explore Strategic Partners A/S Data
ozymf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
ozymf competitorsOZYMF
EVLO
HLUN
NNLX
PXMD
QBIOStock Performance
Full HistoryAbout Strategic Partners A/S
Strategic Partners A/S Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev. Historically, i…
what is strategic partners a/s · ozymf stock overview · strategic partners a/s company profile · who is strategic partners a/s ceo · ozymf OTC · strategic partners a/s headquarters · strategic partners a/s business segments
About Stock Overview & Key Data
Strategic Partners A/S (OZYMF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 16, 2019. As of the latest trading session, OZYMF stock price is $90.00, with a market capitalization of $3.7M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Strategic Partners A/S stock is Sell, with an average 12-month price target of $—. In fiscal year 2025, Strategic Partners A/S reported revenue of $309000.00 and net income of -$859000.00. For detailed data — including Strategic Partners A/S revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Strategic Partners A/S (OZYMF) stock price is $90.00. The stock is traded on OTC under the ticker symbol OZYMF. The 52-week range is $0.09 – $90.00.